Featured Articles
Stay Updated
At the forefront of IP in Canada, we are often aware of changes in Canadian law and practice before they are published or announced, and our professionals proactively report on all new developments in all areas of intellectual property, life sciences, and regulatory law.
Stay up-to-date by subscribing to our email updates.
Court Decisions
Patented Medicines
(Notice of Compliance) Regulations
Regulatory
Market Access / Pricing
Court Proceedings
Resources Centre
Past Issues
2024
2023
-
Rx IP Update
December 2023
-
Rx IP Update
November 2023
-
Rx IP Update
October 2023
-
Rx IP Update
September 2023
-
Rx IP Update
August 2023
-
Rx IP Update
2023 Mid-Year Highlights in Canadian Life Sciences IP and Regulatory Law
-
Rx IP Update
July 2023
-
Rx IP Update
June 2023
-
Rx IP Update
May 2023
-
Rx IP Update
April 2023
-
Rx IP Update
March 2023
-
Rx IP Update
February 2023
-
Rx IP Update
January 2023
-
Rx IP Update
2022 Highlights in Canadian Life Sciences IP and Regulatory Law
2022
-
Rx IP Update
December 2022
-
Rx IP Update
November 2022
-
Rx IP Update
October 2022
-
Rx IP Update
September 2022
-
Rx IP Update
August 2022
-
Rx IP Update
July 2022
-
Rx IP Update
2022 Mid-Year Highlights in Canadian Life Sciences IP and Regulatory Law
-
Rx IP Update
June 2022
-
Rx IP Update
May 2022
-
Rx IP Update
April 2022
-
Rx IP Update
March 2022
-
Rx IP Update
February 2022
-
Rx IP Update
January 2022
-
Rx IP Update
2021 Highlights in Canadian Life Sciences IP and Regulatory Law
2021
-
Rx IP Update
December 2021
-
Rx IP Update
November 2021
-
Rx IP Update
October 2021
-
Rx IP Update
September 2021
-
Rx IP Update
August 2021
-
Rx IP Update
July 2021
-
Rx IP Update
2021 Mid-Year Highlights in Canadian Life Sciences IP and Regulatory Law
-
Rx IP Update
June 2021
-
Rx IP Update
May 2021
-
Rx IP Update
April 2021
-
Rx IP Update
March 2021
-
Rx IP Update
February 2021
-
Rx IP Update
January 2021
-
Rx IP Update
2020 Highlights in Canadian Life Sciences IP and Regulatory Law
2020
-
Rx IP Update
December 2020
-
Rx IP Update
November 2020
-
Rx IP Update
October 2020
-
Rx IP Update
September 2020
-
Rx IP Update
August 2020
-
Rx IP Update
July 2020
-
Rx IP Update
2020 Mid-Year Highlights in Canadian Life Sciences IP and Regulatory Law
-
Rx IP Update
June 2020
-
Rx IP Update
May 2020
-
Rx IP Update
April 2020
-
Rx IP Update
March 2020
-
Rx IP Update
February 2020
-
Rx IP Update
January 2020
-
Rx IP Update
2019 Highlights in Canadian Life Sciences IP and Regulatory Law
2019
-
Rx IP Update
December 2019
-
Rx IP Update
November 2019
-
Rx IP Update
October 2019
-
Rx IP Update
September 2019
-
Rx IP Update
August 2019
-
Rx IP Update
2019 Mid-Year Highlights in Canadian Life Sciences IP
-
Rx IP Update
June 2019
-
Rx IP Update
May 2019
-
Rx IP Update
April 2019
-
Rx IP Update
March 2019
-
Rx IP Update
February 2019
-
Rx IP Update
January 2019
-
Rx IP Update
2018 Highlights in Canadian Life Sciences IP
2018
-
Rx IP Update
December 2018
-
Rx IP Update
November 2018
-
Rx IP Update
October 2018
-
Rx IP Update
September 2018
-
Rx IP Update
August 2018
-
Rx IP Update
Certificates of Supplementary Protection – Transitional Period Ending on September 21, 2018
-
Rx IP Update
July 2018
-
Rx IP Update
2018 Mid-Year Highlights in Canadian Life Sciences IP
-
Rx IP Update
June 2018
-
Rx IP Update
May 2018
-
Rx IP Update
April 2018
-
Rx IP Update
March 2018
-
Rx IP Update
February 2018
-
Rx IP Update
January 2018
-
Rx IP Update
2017 Highlights in Canadian Life Sciences IP
2017
-
Rx IP Update
December 2017
-
Rx IP Update
Special Edition: Canada releases proposed patented medicines pricing regulations
-
Rx IP Update
November 2017
-
Rx IP Update
October 2017
-
Rx IP Update
September 2017
-
Rx IP Update
Publication of Final Regulations on Patent Linkage and Term Restoration related to CETA
-
Rx IP Update
August 2017
-
Rx IP Update
July 2017
-
Rx IP Update
Special Edition: CETA Draft Regulations Published on Patent Linkage and Term Restoration – 15 Day Public Comment Period
-
Rx IP Update
June 2017
-
Rx IP Update
May 2017
-
Rx IP Update
April 2017
-
Rx IP Update
March 2017
-
Rx IP Update
February 2017
-
Rx IP Update
January 2017
-
Rx IP Update
Apotex’s Infringement of AstraZeneca’s Omeprazole Formulation Patent Upheld
-
Rx IP Update
2016 Year in Review
2016
-
Rx IP Update
December 2016
-
Rx IP Update
November 2016
-
Rx IP Update
Implications of CETA and Bill C-30 for pharmaceuticals: Special Release
-
Rx IP Update
October 2016
-
Rx IP Update
September 2016
-
Rx IP Update
August 2016
-
Rx IP Update
July 2016
-
Rx IP Update
2016 Mid-Year Highlights
-
Rx IP Update
June 2016
-
Rx IP Update
May 2016
-
Rx IP Update
April 2016
-
Rx IP Update
March 2016
-
Rx IP Update
February 2016
-
Rx IP Update
January 2016
-
Rx IP Update
2015 Highlights
2015
-
Rx IP Update
December 2015
-
Rx IP Update
November 2015 Special Edition
-
Rx IP Update
November 2015
-
Rx IP Update
October 2015
-
Rx IP Update
September 2015
-
Rx IP Update
August 2015
-
Rx IP Update
July 2015 Special Edition
-
Rx IP Update
Rx IP Update 2015 Mid-Year Highlights
-
Rx IP Update
July 2015
-
Rx IP Update
June 2015 Special Edition
-
Rx IP Update
June 2015
-
Rx IP Update
May 2015
-
Rx IP Update
May 2015 Special Edition
-
Rx IP Update
April 2015
-
Rx IP Update
March 2015 Special Edition
-
Rx IP Update
March 2015
-
Rx IP Update
February 2015
-
Rx IP Update
January 2015
-
Rx IP Update
2014 Highlights